Off-label use and the challenges here in Canada were mentioned, because you can have a physician giving a patient something that maybe it wasn't originally intended for but they're finding that it does have an effect.
What would be the regulatory challenges to allowing more of this off-label use of product to be recognized on the formularies for certain purposes, and as was brought up, perhaps for reimbursement for patients in that situation?